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Zika virus (ZIKV) infection is an emerging pandemic vi-
ral disease that has been declared as a public health emer-
gency by the World Health Organization (WHO, 2016). It
has raised public concern from all around the globe due to
the widespread nature of the infection at an alarming pace.
ZIKV infection is a mosquito − borne disease, which
spreads primarily through the bite of an infected mosquito
(Aedes species) (Fauci & Morens, 2016). The other routes
of spread include intrauterine transmission, sexual contact,
and blood transfusion (Besnard et al., 2014 ; D’Ortenzio et
al., 2016 ; Musso et al, 2014). Although the majority of pa-
tients show mild symptoms such as fever, conjunctivitis, cu-
taneous rash, and arthralgia, this infection often causes birth
defects, growth and developmental anomalies, including mi-
crocephaly, and some motor neurological manifestations in
adults (Cao−Lormeau et al., 2016). Due to the increasing
number of cases of microcephaly associated with ZIKV, it
can significantly affect the dental and general health of the
patient. Since the ZIKV might be transmitted through body
fluids including blood and saliva (Musso et al, 2014 ; Musso
et al., 2015), dental practitioners should be made aware of
the risk of infection. Saliva obtained from patients may be
useful for a diagnostic approach. Reports about the involve-
ment of ZIKV infection in dentistry are limited. Therefore,
this review aimed to demonstrate and discuss the importance
of awareness about ZIKV infection in the dental setting.
????????????
ZIKV originated from the Zika forest in Uganda and was
isolated from a rhesus monkey in 1947 (Dick, 1953). The
first human case of ZIKV was detected in 1952, after which
it spread to other geographical regions such as Egypt
(Smithburn KC et al., 1954), East Africa (Smithburn KC,
1952), Nigeria (Macnamara FN, 1954), India (Smithburn KC
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Zika virus (ZIKV) infection, which spreads through
the bite of an infected mosquito (Aedes species), is a
global public health problem. Although about 80% of
patients remain asymptomatic, infected individuals
demonstrate common features such as fever, cutaneous
rash, arthralgia, and conjunctivitis. ZIKV is known to
be associated with neurological complications, such as
microcephaly and Guillain–Barre syndrome. The virus
spreads through contact with blood, semen, and vaginal
fluids. However, it has been detected in many other hu-
man body fluids, including urine, amniotic fluid, breast
milk, saliva, cerebrospinal fluid, and cervical mucous.
As dental professionals frequently come in contact with
saliva and blood, it is imperative that they protect
themselves from ZIKV−infected patients and instruct
them to avoid the transmission of this virus. In addi-
tion, saliva can be used as a diagnostic tool for ZIKV
infection. A saliva−based test may prove effective, and
dental professionals might be expected to play a key





et al, 1954), Japan (Taira M et al., 2017), Thailand (Pond
WL, 1963), Vietnam (Smithburn KC et al, 1954), the Philip-
pines (Hammon et al., 1958) and Malaysia (Smithburn KC
et al, 1954), affecting more than 80 countries worldwide.
During the outbreak of ZIKV in 2007 on several islands in
the state of Yap, 5000 people were affected, while the out-
break in French Polynesia in 2013–2014 resulted in a total
of 32,000 people who were affected by the virus (Schuler−
Faccini et al., 2016). Thousands of babies were born with
devastating birth defects after their mothers were infected in
pregnancy. In 2015, a sudden increase in the cases of micro-
cephaly in infants and the association of the Guillain–Barre
syndrome was reported in Brazil (Schuler−Faccini et al. ,
2016). By 2016, almost 4300 cases of microcephaly had
been recorded (Victora et al., 2016). However, by 2017, the
number of infections had decreased owing to the several
precautions that were taken into consideration. The WHO
counted 12 outbreaks worldwide in 2015, 22 in 2016, and
just one in early 2017. The Centers for Disease Control
(CDC) and Prevention in the United States of America (US)
recently deactivated its emergency response system for
ZIKV that was launched in January 2016 (WHO, 2017). Al-
though the number of infected cases has decreased, it is not
completely controlled and can result in another outbreak in
future. A revised guideline has been adapted by the Euro-
pean Centre for Disease Prevention and Control (ECDC) and
WHO as a country−wise classification (WHO, 2017).
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ZIKV is mainly transmitted by the bite of the Aedes mos-
quito (Marchette et al., 1969). Transplacental transmission or
transmission during delivery by an infected mother has also
been reported (Besnard et al., 2014). Zika viral RNA has
been detected in breast milk, which raises the concern of po-
tential transmission by breastfeeding (Besnard et al., 2014).
Sexual transmission was reported in a few instances (Musso
et al., 2015 ; Fig.1). The Zika viral RNA has also been de-
tected in urine at higher loads, which may hint at possibility
of a person−to−person transmission route ; in addition, it in-
dicates the possibility of testing the urine after the early
symptoms of viraemia have subsided ( Fauci & Morens,
2016). The virus has been found to be transmitted via blood
transfusion (Musso et al., 2014). A recent study indicated
that the viral RNA was detected in blood samples from as-
ymptomatic donors, and the number of positive results was
unexpectedly high (3% ; Musso et al., 2014). On February
16, 2016, the Food and Drug Administration in the US rec-
ommended the deferral of blood donations from individuals
who had traveled to areas with active ZIKV transmission,
were potentially exposed to the virus, or had experienced a
confirmed ZIKV infection (Zuanazzi et al., 2017).
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ZIKV is characterized as an asymptomatic or mild dengue
−like disease with fever, headache, myalgia, muscle and
joint aches, conjunctivitis, and maculopapular rashes, with
an incubation period of 3 to 12 days (Zuanazzi et al., 2017 ;
CDC, 2016 ; Fig.1). Only about 20% of cases are sympto-
matic (CDC, 2016). There is no specific anti−viral treatment
for this condition, and the management of symptoms may
include the use of analgesics and antipyretics. However,
over the period of 60 years of observation, ZIKV has not
been reported to cause hemorrhagic fever or death (Fauci &
Morens, 2016). The most significant public health concern is
the recently confirmed association between ZIKV infection
during pregnancy and microcephaly or other severe fetal
brain defects (Schuler−Faccini et al., 2016). The relationship
between ZIKV infection and microcephaly has long been
suspected, based on the detection of Zika viral RNA in
mothers and in amniotic fluid samples from fetuses, which
indicates the potential of this virus to infect fetuses. Incom-
plete viral autophagy, centrosome abnormalities, and chro-
mosomal instability have been observed in Zika− infected
cells. Notably, no other flavivirus has been associated with
teratogenic effects in humans. Guillain−Barré syndrome, an
autoimmune disease causing acute or subacute flaccid pa-
ralysis, has also been found to be associated with ZIKV in-
fection ( Cao − Lormeau et al. , 2016 ; Zuanazzi D et al. ,
2017 ; CDC, 2016).
????????? ?? ???? ?? ??????
Although the transmission of ZIKV through saliva has not
been substantiated so far, its presence in saliva has been de-
tected (Musso et al., 2015). Exposure to the saliva of in-
fected patients can be considered as a possible, yet unlikely,
route of infection. The virus has been recovered in cell cul-
tures from the saliva of infected patients and has also been
detected in saliva from patients with Zika fever, especially
during the acute phase of the disease (Musso et al., 2015 ;
Bonaldo et al., 2016). ZIKV peptides can be detected in the
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Figure 1. Mode of transmission of Zika virus
a. Vector borne transmission. Zika virus is transmitted by the bite of the Aedes mosquito. When a healthy
mosquito bites a Zika infected patient/monkey, it sucks the virus−infected blood. The virus replicates inside
mosquito gut, and is then transmitted to a healthy human when it is bitten by the carrier mosquito.
b. Non−vector born transmission. Human−to−human transmission through sexual transmission, perinatal and
blood transfusion. Monkey to human transmission through the bite of a Zika−infected monkey. The clinical
features include headache/fever, conjunctivitis, and muscle/joint pain. Complications such as microcephaly in
new−born babies and Guillain−Barre syndrome in adults may occur.
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saliva of patients previously diagnosed with Zika fever, indi-
cating that ZIKV may be latent in the salivary gland (Bal-
thesen et al., 1994). Viruses such as herpes simplex virus
types 1 and 2 (HSV1, HSV2) and cytomegalovirus (CMV)
can be transmitted through saliva (Barzon et al., 2016). Sa-
liva may play a critical role in the human−to−human trans-
mission of ZIKV. Nevertheless, to the best of our knowl-
edge, there is no information about the transmission of Zika
via saliva in the literature. Thus, further studies are needed
to determine this phenomenon.
From another point of view, saliva can be used as a diag-
nostic sample for ZIKV infection (Bonaldo et al., 2016). In
fact, it has been already used as a source for ZIKV diagnos-
tics when the first cases were reported during the 2014 out-
break in French Polynesia (Barzon et al., 2016). Recently,
many reports confirmed that viral load (as determined by
RNA levels) is significantly higher in saliva than in plasma ;
ZIKV RNA could be detected for a much longer period in
saliva than in plasma (Barzon et al., 2016). Moreover, it was
detected in the saliva of the patient even during the conva-
lescent phase (Balthesen et al., 1994). A saliva−based test
may be effective, and dental professionals may play a key
role in the future surveillance and detection of this virus
(Balthesen et al., 1994).
???? ?????????????? ?? ???????? ???? ???? ??????
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Several dental problems such as delay in the eruption of
deciduous dentition, hypersalivation, higher chances of car-
ies development, and the presence of enamel alterations con-
sistent with dental hypoplasia have been observed in chil-
dren with microcephaly associated with prenatal ZIKV in-
fection (Cavalcanti, 2017). Therefore, it is essential for the
dental professional to provide proper attention to the patient
during dental care and adequate information regarding oral
hygiene and eating habits to the caretakers and family. Se-
vere neurological complications associated with Guillain −
Barre syndrome have been described in postnatal ZIKV in-
fections (Passi et al., 2017). Patients with Guillain−Barre
syndrome present with muscle weakness caused due to the
damage of the peripheral nervous system by the immune
system. Facial muscle weakness with disorders of muscle
movement and swallowing are often observed in these pa-
tients (Rajabally et al., 2012). Nonetheless, no specific oro-
facial manifestations have been reported so far. A recent pa-
per reported the presence of hyperemia and petichae in the
hard palate of a patient with ZIKV. Since ZIKV are neu-
rotropic viruses, which are capable of infecting and replicat-
ing in neural cells (Brasil et al., 2016), they may persist in
the latent state and are reactivated at a later period, as in the
cases of HSV that cause recurrent ulcerations in the oral mu-
cosa. ZIKV could invade endothelial cells, fibroblasts, and
keratinocytes via receptors in the oral mucosal tissues (Brasil
et al. , 2016), causing specific oral pathogenic conditions.
However, further investigations are needed to determine the
presence of oral specific manifestations.
???? ?? ?????? ????????????? ??? ???? ?????????
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No appropriate treatment strategy or vaccine for ZIKV is
available thus far. Protection of dentists from the infection
and avoiding the transmission of this condition to other pa-
tients is crucial. Both saliva and blood are known to be the
routes for transmission of ZIKV infection during dental pro-
cedures. Active participation of dental professionals for the
screening of ZIKV infected patients and their adherence to
infection control guidelines are of utmost importance in con-
trolling the dissemination of ZIKV infection. It is advisable
for dental professionals, who encounter suspected patients
with ZIKV infections, to report them to the local health de-
partment for further investigations (CDC, 2016).
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